Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combination effect of cetuximab with radiation in colorectal cancer cells.

Tumori - 1 Jan 2000

Shin Hye Kyung, Kim Mi-Sook, Lee Jin Kyung, Lee Seung-Sook, Ji Young Hoon, Kim Jong-Il, Jeong Jae-Hoon

Abstract excerpt

AIMS AND BACKGROUND: Colorectal cancer (CRC) is one of the commonest malignant disorders and frequently associated with high expression of epidermal growth factor receptor (EGFR), resulting in advanced disease and a poor prognosis. In this study, we investigated the radiosensitizing effects of the selective EGFR inhibitor cetuximab in human CRC cell lines. METHODS: Four human CRC cell lines, CaCo-2, HCT-8, LoVo,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Annexin A5
Share to Caco-2 Cells
Share to Cetuximab

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Radiation-Sensitizing Agents

Share to Radiotherapy, Adjuvant

Share to Transplantation, Heterologous

Share to Tumor Stem Cell Assay

Source

Identifiers

PMID: 21302618
DOI: 10.1177/030089161009600513

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combination effect of cetuximab with radiation in colorectal cancer cells.PMID 21302618Read ↗

[Association of epithermal growth factor receptor expression and its downstream gene mutation status with radiosensitivity of colorectal carcinoma cell lines in vitro].Semantic proximity Read ↗

KZ02 enhances the radiosensitivity of BRAF-mutated CRC in vitro and in vivo.Semantic proximity Read ↗

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal CancerSemantic proximity Read ↗

Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer.Semantic proximity Read ↗

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.Semantic proximity Read ↗

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiationSemantic proximity Read ↗

Progeny From Irradiated Colorectal Cancer Cells Acquire an EMT‐Like Phenotype and Activate Wnt/β‐Catenin PathwaySemantic proximity Read ↗

Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations.Semantic proximity Read ↗

Unexpected effect of the monoclonal antibody Panitumumab on human cancer cells with different KRAS status.Semantic proximity Read ↗

Effects of pemetrexed, gefitinib, and their combination on human colorectal cancer cells.Semantic proximity Read ↗

Efficacy and toxicity of adding cetuximab to chemotherapy in the treatment of metastatic colorectal cancer: a meta-analysis from 12 randomized controlled trials.Semantic proximity Read ↗

Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.